UA66809C2 - Спосіб лікування гіперглікемії похідною тіазолідиндіону - Google Patents

Спосіб лікування гіперглікемії похідною тіазолідиндіону

Info

Publication number: UA66809C2
Authority: UA; Ukraine
Prior art keywords: hyperglycaemia; treatment; mammal; pharmaceutically acceptable; need
Prior art date: 1997-10-13

Application number

UA2000042049A

Other languages

English (en)

Russian (ru)

Ukrainian (uk)

Inventor

Робін Едвін Букінгем

Стефен Елістер Сміт

Original Assignee

Смітклайн Бічам Плс

Смитклайн Бичам Плс

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-13

Filing date

1998-10-12

Publication date

2004-06-15

1998-10-12 Application filed by Смітклайн Бічам Плс, Смитклайн Бичам Плс filed Critical Смітклайн Бічам Плс

2004-06-15 Publication of UA66809C2 publication Critical patent/UA66809C2/uk

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
Emergency Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

UA2000042049A 1997-10-13 1998-10-12 Спосіб лікування гіперглікемії похідною тіазолідиндіону UA66809C2 (uk)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9721692.3A GB9721692D0 (en)	1997-10-13	1997-10-13	Novel treatment
PCT/GB1998/003067 WO1999018944A1 (en)	1997-10-13	1998-10-12	Use of thiazolidinediones for the treatment of hyperglycaemia

Publications (1)

Publication Number	Publication Date
UA66809C2 true UA66809C2 (uk)	2004-06-15

Family

ID=10820481

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
UA2000042049A UA66809C2 (uk)	1997-10-13	1998-10-12	Спосіб лікування гіперглікемії похідною тіазолідиндіону

Country Status (24)

Country	Link
EP (1)	EP1023057A1 (xx)
JP (1)	JP2001519383A (xx)
KR (1)	KR20010024482A (xx)
CN (1)	CN1281358A (xx)
AP (1)	AP1223A (xx)
AU (1)	AU9547198A (xx)
BG (1)	BG104405A (xx)
BR (1)	BR9815220A (xx)
CA (1)	CA2305289A1 (xx)
CZ (1)	CZ20001298A3 (xx)
EA (1)	EA200000418A1 (xx)
GB (1)	GB9721692D0 (xx)
HR (1)	HRP20000256A2 (xx)
HU (1)	HUP0003673A3 (xx)
ID (1)	ID24439A (xx)
IL (1)	IL135515A0 (xx)
NO (1)	NO20001897L (xx)
OA (1)	OA11519A (xx)
PL (1)	PL339804A1 (xx)
SK (1)	SK5322000A3 (xx)
TR (1)	TR200000957T2 (xx)
UA (1)	UA66809C2 (xx)
WO (1)	WO1999018944A1 (xx)
YU (1)	YU28700A (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7045519B2 (en)	1998-06-19	2006-05-16	Chiron Corporation	Inhibitors of glycogen synthase kinase 3
AP2001002036A0 (en) *	1998-07-21	2001-03-31	Smithkline Beecham Plc	Use of glucose uptake enhancer for reducing apoptosis.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0306228B1 (en) *	1987-09-04	1999-11-17	Beecham Group Plc	Substituted thiazolidinedione derivatives
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
US5457109A (en) *	1993-09-15	1995-10-10	Warner-Lambert Company	Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus

1997
- 1997-10-13 GB GBGB9721692.3A patent/GB9721692D0/en not_active Ceased
1998
- 1998-10-12 CA CA002305289A patent/CA2305289A1/en not_active Abandoned
- 1998-10-12 CZ CZ20001298A patent/CZ20001298A3/cs unknown
- 1998-10-12 PL PL98339804A patent/PL339804A1/xx unknown
- 1998-10-12 HR HR20000256A patent/HRP20000256A2/hr not_active Application Discontinuation
- 1998-10-12 BR BR9815220-3A patent/BR9815220A/pt not_active Application Discontinuation
- 1998-10-12 IL IL13551598A patent/IL135515A0/xx unknown
- 1998-10-12 EP EP98949088A patent/EP1023057A1/en not_active Withdrawn
- 1998-10-12 AP APAP/P/2000/001788A patent/AP1223A/en active
- 1998-10-12 KR KR1020007003935A patent/KR20010024482A/ko not_active Ceased
- 1998-10-12 JP JP2000515579A patent/JP2001519383A/ja active Pending
- 1998-10-12 SK SK532-2000A patent/SK5322000A3/sk unknown
- 1998-10-12 WO PCT/GB1998/003067 patent/WO1999018944A1/en not_active Ceased
- 1998-10-12 OA OA1200000107A patent/OA11519A/en unknown
- 1998-10-12 YU YU28700A patent/YU28700A/sh unknown
- 1998-10-12 ID IDW20000670A patent/ID24439A/id unknown
- 1998-10-12 TR TR2000/00957T patent/TR200000957T2/xx unknown
- 1998-10-12 UA UA2000042049A patent/UA66809C2/uk unknown
- 1998-10-12 EA EA200000418A patent/EA200000418A1/ru unknown
- 1998-10-12 AU AU95471/98A patent/AU9547198A/en not_active Abandoned
- 1998-10-12 HU HU0003673A patent/HUP0003673A3/hu unknown
- 1998-10-12 CN CN98812016A patent/CN1281358A/zh active Pending
2000
- 2000-04-12 NO NO20001897A patent/NO20001897L/no not_active Application Discontinuation
- 2000-05-05 BG BG104405A patent/BG104405A/xx unknown

Also Published As

Publication number	Publication date
YU28700A (sh)	2003-10-31
AP2000001788A0 (en)	2000-06-30
CA2305289A1 (en)	1999-04-22
OA11519A (en)	2004-02-09
EP1023057A1 (en)	2000-08-02
WO1999018944A1 (en)	1999-04-22
AU9547198A (en)	1999-05-03
PL339804A1 (en)	2001-01-02
JP2001519383A (ja)	2001-10-23
BR9815220A (pt)	2000-11-14
CN1281358A (zh)	2001-01-24
NO20001897D0 (no)	2000-04-12
CZ20001298A3 (cs)	2001-08-15
TR200000957T2 (tr)	2000-08-21
NO20001897L (no)	2000-06-09
EA200000418A1 (ru)	2000-10-30
HRP20000256A2 (en)	2000-12-31
HUP0003673A2 (hu)	2001-10-28
IL135515A0 (en)	2001-05-20
AP1223A (en)	2003-11-13
HUP0003673A3 (en)	2001-12-28
GB9721692D0 (en)	1997-12-10
BG104405A (en)	2000-12-29
KR20010024482A (ko)	2001-03-26
SK5322000A3 (en)	2000-09-12
ID24439A (id)	2000-07-20

Publication	Publication Date	Title
SG127714A1 (en)	2006-12-29	Method of treating metabolic disorders, especiallydiabetes, or a disease or condition associated wi th diabetes
BG105568A (en)	2002-01-31	Pharmaceutical compositions for modified release of an insulin sensitiser and another antidiabetic agent
EP1127579A3 (en)	2004-01-21	Method for increasing bioavailability of oral pharmaceutical compositions
WO2000016762A3 (en)	2000-05-25	Method for reducing nicotine dependency
PL325825A1 (en)	1998-08-03	Microemulsion for use as a carrier for administering active compounds
AU5263496A (en)	1996-10-23	Targeted catheter drug administration
EP1574219A3 (en)	2006-04-26	Method of inhibiting fibrosis with a somatostatin agonist
NZ514574A (en)	2004-02-27	Novel method of treatment
LU91138I2 (fr)	2005-04-04	Glulisine d'insuline et ses dérivés pharmaceutiquement acceptables.
MX9602683A (es)	1997-06-28	Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
MY121517A (en)	2006-01-28	Anticonvulsant derivatives useful in reducing blood glucose levels
WO1999004772A3 (en)	1999-04-08	Use of levobupivacaine
CA2253130A1 (en)	1999-05-06	A medicament for treating obesity and improving lipid metabolism
BG104059A (en)	2000-10-31	Diabetes treatment with rosiglytazone and insulin
CA2280773A1 (en)	1998-08-13	Methods for the administration of amifostine
AP1901A (en)	2008-10-24	Pharmaceutical composition for modified release insulin sensitiser.
CA2190837A1 (en)	1995-11-30	Transdermal delivery of anti-epileptic drugs
BG104058A (en)	2000-10-31	Diabetes treatment with thiazolydindion and sulphonylurea
UA66809C2 (uk)	2004-06-15	Спосіб лікування гіперглікемії похідною тіазолідиндіону
BG101884A (en)	1998-10-30	Salts of the clavulanic acid
MY138246A (en)	2009-05-29	Treatment of diabetes with thiazolidione and sulphonylurea.
AP9901720A0 (en)	1999-12-31	Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitors.
TW330933B (en)	1998-05-01	Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
CA2234936A1 (en)	1999-10-17	Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine
NZ503862A (en)	2003-01-31	Use of insulin sensitisers (especially thiazolidinediones) for the treatment of hyperglycaemia